Free Trial

ARS Pharmaceuticals (SPRY) Insider Trading & Ownership

$13.12
-0.28 (-2.09%)
(As of 09:47 AM ET)

ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
40.10%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$40.49 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$12.83 M
Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SPRY Insider Buying and Selling by Quarter

ARS Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00  
8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00  
8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00  
8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00  
7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00  
7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00  
6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30  
6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00  
5/16/2024Sarina TanimotoInsiderSell89,096$9.06$807,209.76  
5/15/2024Richard E LowenthalCEOSell5,147$9.05$46,580.35  
5/14/2024Sarina TanimotoInsiderSell5,757$9.01$51,870.57  
5/7/2024Sarina TanimotoInsiderSell100,000$9.34$934,000.00  
4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.00  
4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.00  
3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.66  
3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.00  
3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.04  
3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.86  
3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.00  
3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.54  
3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.84  
3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.00  
3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.00  
2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.64  
2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.56  
2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.00  
9/28/2023Alexander A FitzpatrickInsiderBuy40,000$3.62$144,800.00  
9/21/2023Ra Capital Management, L.P.DirectorBuy2,700,000$3.03$8,181,000.00  
9/1/2023Laura ShawverDirectorSell100,000$7.71$771,000.00  
8/29/2023Ra Capital Management, L.P.DirectorBuy3,750,000$6.20$23,250,000.00  
(Data available from 1/1/2013 forward)

SPRY Insider Trading Activity - Frequently Asked Questions

Who is on ARS Pharmaceuticals's Insider Roster?

The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brian Dorsey, Eric Karas, Kathleen D Scott, Laura Shawver, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY.

What percentage of ARS Pharmaceuticals stock is owned by insiders?

40.10% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings.

Which ARS Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), Kathleen D Scott ($51,480.00), and Ra Capital Management, L.P. ($40,348,945.66).

How much insider buying is happening at ARS Pharmaceuticals?

Insiders have purchased a total of 7,441,804 SPRY shares in the last 24 months for a total of $40,545,225.66 bought.

Which ARS Pharmaceuticals insiders have been selling company stock?

The following insiders have sold SPRY shares in the last 24 months: Brian Dorsey ($750,000.00), Eric Karas ($140,000.00), Kathleen D Scott ($200,000.00), Laura Shawver ($2,276,913.11), Richard E Lowenthal ($5,488,888.41), and Sarina Tanimoto ($5,482,632.05).

How much insider selling is happening at ARS Pharmaceuticals?

Insiders have sold a total of 1,506,927 ARS Pharmaceuticals shares in the last 24 months for a total of $14,338,433.57 sold.


This page (NASDAQ:SPRY) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners